WORLDSymposium 2018 attracted over 25 Exhibitors offering a highly interactive forum for discussion of lysosomal diseases with international researchers and health care practitioners. View Exhibitor and Patient Advocate list.
15 Satellite symposia were held from Monday February 5, 2018 to Thursday, February 8, 2018. Click here for the full schedule.
In 2018, over 410 scientific abstracts were presented at four separate poster sessions beginning on Tuesday, February 6, 2018, and remained open throughout the rest of the conference. View Poster List.
Following the presentation of the Award for Innovation and Accomplishment in lysosomal disease research, presentations in the morning and afternoon sessions discussed innovations in technology and how they can be applied to early diagnosis for lysosomal conditions, progress in gene therapy, and exploitation of differences at the cellular level that may indicate early disease state. View full program.
For the sixth consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, February 5, 2018. See agenda and faculty.
The WORLDSymposium 2018 New Treatment Awards were presented to Biomarin and to Ultragenyx on Thursday, February 5, 2018. More details.
WORLDSymposium was pleased to announce the 10 recipients of the 2018 Young Investigator Awards on Monday, February 5. Click to view award recipients.
Mark E. Haskins, VMD, PHD Received the 2018 Roscoe O. Brady Award for Innovation and Accomplishment on Tuesday, February 6, 2018. Dr. Haskins has a career that spans over 40 years, from his beginning as a NIH Medical Genetics Trainee in 1975 working on MPS VI, through his appointment as Professor Emeritus in 2014. More details.
WORLDSymposium 2018 Patient Advocate Leader (PAL) Award was received by Jack Johnson on Wednesday, February 7, 2018. Jack is a founding member and Executive Director of the Fabry Support & Information Group (FSIG) in the United States, and is also a founding member and Vice President and Board Member of the Fabry International Network (FIN). More details.
Petra Kaufmann, MD, MSc delivered Keynote on Wednesday, February 7, 2018 and R. Rodney Howell, MD Delivered Keynote on Thursday, February 8, 2018. Petra Kaufmann is director of the NCATS Office of Rare Diseases Research. Her work includes overseeing the Rare Diseases Clinical Research Network program, Genetic and Rare Diseases Information Center, and the NCATS Toolkit for Patient-Focused Therapy Development. R. Rodney Howell, MD is Professor of Pediatrics and a Member of the Hussman Institute for Human Genomics, at the Miller School of Medicine of the University of Miami. Read speaker bios.